Perimeter Solutions to acquire MMT for $685M; expects close in Q1 2026

Perimeter Solutions, Inc.

Acquires MMT, a medical device machinery provider, for ~$685M in cash from Arcline Investment Management.
MMT expected 2025 revenue ~$140M and Adjusted EBITDA ~$50M.
Funding: $500M new secured debt + $185M cash on hand; pro forma net leverage ~2.7x LTM EBITDA.
Transaction expected to close in Q1 2026, subject to HSR and customary conditions.
Perimeter CEO cites strong fit with decentralized operating structure and aftermarket growth.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Perimeter Solutions, Inc. entered into Securities Purchase Agreement with the equity holders of MMT (the "Sellers") valued at $685 million in cash (effective 2025-12-09).

Action: entry
Agreement: equity purchase
Counterparty: the equity holders of MMT (the "Sellers")
Value: $685 million in cash
Effective: 2025-12-09

Exact text from the filing

On December 9, 2025, Perimeter Solutions North America, Inc., a Delaware corporation (the “Buyer”), a wholly-owned subsidiary of Perimeter Solutions, Inc. (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”), by and among the Buyer, the Company, Thunderbird Midco, LLC, a Delaware limited liability company, and its subsidiaries (“MMT”), the equity holders of MMT (the “Sellers”), and certain other parties thereto pursuant to which the Buyer will acquire all of the outstanding capital stock of MMT from the Sellers for $685 million in cash, subject to certain customary adjustments as set forth in the Purchase Agreement (the “Acquisition”).

View on SEC.gov

Browse all material agreements →

Perimeter Solutions, Inc. filing history →

Source: SEC EDGAR

accession 0001880319-25-000143

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.